Search by First Name and/or Last Name. Results are displayed in descending publication year and then sorted ascending by the reference field. Need to submit a publication reference?
Name: Suzanne Schindler
Year: 2023
Reference:
Barthélemy NR, Saef B, Li Y, Gordon BA, He Y, Horie K, Stomrud E, Salvadó G, Janelidze S, Sato C, Ovod V, Henson RL, Fagan AM, Benzinger TLS, Xiong C, Morris JC, Hansson O, Bateman RJ, Schindler SE. CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease. Nature Aging. 2023. 1-11.
Name: Suzanne Schindler
Year: 2023
Reference:
Bayat S, Roe CM, Schindler S, Murphy SA, Doherty JM, Johnson AM, Walker A, Ances BM, Morris JC, Babulal GM. Everyday Driving and Plasma Biomarkers in Alzheimer’s Disease: Leveraging Artificial Intelligence to Expand Our Diagnostic Toolkit. J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-221268. Epub ahead of print. PMID: 36938737.
Name: Susan Stark
Year: 2023
Reference:
Bollinger RM, Gabel M, Coble DW, Chen SW, Keleman A, Doralus J, Chin E, Lingler JH, Grill JD, Stark SL, Edwards DF. Retention of study partners in longitudinal studies of Alzheimer disease. Submitted to Journal of Alzheimer’s Disease
Name: Suzanne Schindler
Year: 2023
Reference:
Brand AL, Lawler PE, Bollinger JG, Li Y, Schindler SE, Li M, Lopez S, Ovod V, Nakamura A, Shaw LM, Zetterberg H, Hansson O, Bateman RJ. The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review. Alzheimers Res Ther. 2022 Dec 27;14(1):195. doi: 10.1186/s13195-022-01117-1. PMID: 36575454; PMCID: PMC9793600.
Name: Suzanne Schindler
Year: 2023
Reference:
Cooley SA, Nelson B, Boerwinkle A, Yarasheski KE, Kirmess KM, Meyer MR, Schindler SE, Morris JC, Fagan A, Ances BM, O’Halloran J. Plasma Aβ42/Aβ40 ratios are not reduced in older people living with HIV. Clin Infect Dis. 2023 Jan 5:ciad001. doi: 10.1093/cid/ciad001. Epub ahead of print. PMID: 36610788.
Name: Susan Stark
Year: 2023
Reference:
Keleman AA, Chang CH, Bollinger RM, Lingler JH, Gabel M, Stark SL. Psychometric evaluation of the Perceived Research Burden Assessment (PeRBA) in longitudinal studies of Alzheimer disease using rasch analysis. Alzheimer Disease & Associated Disorders 2023;37(1):28-34.
Name: Susan Stark
Year: 2023
Reference:
Keleman AA, Nicosia J, Bollinger RM, Wisch, Hassesnstab J, Morris JC, Ances BM, Balota DA, Stark SL. It’s the body, not the brain: Precipitating mechanisms of falls in preclinical Alzheimer disease. Submitted to Journal of Alzheimer’s Disease Reports.
Name: Suzanne Schindler
Year: 2023
Reference:
Oh IY, Schindler SE, Ghoshal N, Lai AM, Payne PRO, Gupta A. Extraction of clinical phenotypes for Alzheimer’s disease dementia from clinical notes using natural language processing. JAMIA Open. 2023 Feb 24;6(1):ooad014. doi: 10.1093/jamiaopen/ooad014. PMID: 36844369; PMCID: PMC9952043.
Name: Suzanne Schindler
Year: 2023
Reference:
Schindler SE, Atri A. The role of cerebrospinal fluid and other biomarker modalities in the Alzheimer’s disease diagnostic revolution. Nature Aging. In press.
Name: Suzanne Schindler
Year: 2023
Reference:
Wisch JK, Gordon BA, Boerwinkle AH, Luckett PH, Bollinger JG, Ovod V, Li Y, Henson RL, West T, Meyer MR, Kirmess KM, Benzinger TLS, Fagan AM, Morris JC, Bateman RJ, Ances BM, Schindler SE. Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40. Alzheimers Dement (Amst). 2023 Mar 2;15(1):e12405. doi: 10.1002/dad2.12405. PMID: 36874595; PMCID: PMC9980305.
Name: Andrew Aschenbrenner
Year: 2022
Reference:
Aschenbrenner AJ, Li Y, Henson RL, Volluz K, Hassenstab J, Verghese P, West T, Meyer MR, Kirmess KM, Fagan AM, Xiong C, Holtzman D, Morris JC, Bateman RJ, Schindler SE. Comparison of plasma and CSF biomarkers in predicting cognitive decline. Ann Clin Transl Neurol. 2022 Oct 2. doi: 10.1002/acn3.51670. Epub ahead of print. PMID: 36183195.
Format:
Name: Suzanne Schindler
Year: 2022
Reference:
Aschenbrenner AJ, Li Y, Henson RL, Volluz K, Hassenstab J, Verghese P, West T, Meyer MR, Kirmess KM, Fagan AM, Xiong C, Holtzman D, Morris JC, Bateman RJ, Schindler SE. Comparison of plasma and CSF biomarkers in predicting cognitive decline. Ann Clin Transl Neurol. 2022 Oct 2. PMID: 36183195.
Name: Andrew Aschenbrenner
Year: 2022
Reference:
Aschenbrenner AJ, Murphy SA, Doherty JM, Johnson AM, Bayat S, Walker A, Peña Y, Hassenstab J, Morris JC, Babulal GM. Neuropsychological correlates of changes in driving behavior among clinically healthy older adults. J Gerontol B Psychol Sci Soc Sci. 2022 Jul 23:gbac101. doi: 10.1093/geronb/gbac101. Epub ahead of print. PMID: 35869666.
Format:
Name: Suzanne Schindler
Year: 2022
Reference:
Brand AL, Lawler PE, Bollinger JG, Li Y, Schindler SE, Li M, Lopez S, Ovod V, Nakamura A, Shaw LM, Zetterberg H, Hansson O, Bateman RJ. The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review. Alzheimers Res Ther. 2022 Dec 27;14(1):195. doi: 10.1186/s13195-022-01117-1. PMID: 36575454; PMCID: PMC9793600.
Name: Anne Fagan
Year: 2022
Reference:
Casaletto KB, Kornack J, Paolillo EW, Rojas JC, VandeBunte A, Staffaroni AS, Lee S, Heuer H, Forsberg L, Ramos EM, Miller BL, Kramer JH, Yaffe K, Petrucelli L, Boxer A, Boeve B, Gendron TF, Rosen H; ALLFTD Consortium. Association of Physical Activity With Neurofilament Light Chain Trajectories in Autosomal Dominant Frontotemporal Lobar Degeneration Variant Carriers. JAMA Neurol. 2022 Nov 14:e224178. doi: 10.1001/jamaneurol.2022.4178. Epub ahead of print. PMID: 36374516; PMCID: PMC9664369.
Name: Sarah Hartz
Year: 2022
Reference:
Hartz SM, Mozersky J, Schindler SE, Linnenbringer E, Wang J, Gordon BA, Raji CA, Moulder KL, West T, Benzinger TLS, Cruchaga C, Hassenstab JJ, Bierut LJ, Xiong C, Morris JC. A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer’s disease dementia. Alzheimers Dement. 2022 Sep 30. doi: 10.1002/alz.12781. Epub ahead of print. PMID: 36178120.
Name: Suzanne Schindler
Year: 2022
Reference:
Hartz SM, Mozersky J, Schindler SE, Linnenbringer E, Wang J, Gordon BA, Raji CA, Moulder KL, West T, Benzinger TLS, Cruchaga C, Hassenstab JJ, Bierut LJ, Xiong C, Morris JC. A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer’s disease dementia. Alzheimers Dement. 2022 Sep 30. PMID: 36178120.
Name: Anne Fagan
Year: 2022
Reference:
Joseph-Mathurin N, Llibre-Guerra JJ, Li Y, McCullough AA, Hofmann C, Wojtowicz J, Park E, Wang G, Preboske GM, Wang Q, Gordon BA, Chen CD, Flores S, Aggarwal NT, Berman SB, Bird TD, Black SE, Borowski B, Brooks WS, Chhatwal JP, Clarnette R, Cruchaga C, Fagan AM, Farlow M, Fox NC, Gauthier S, Hassenstab J, Hobbs DA, Holdridge KC, Honig LS, Hornbeck RC, Hsiung GR, Jack CR Jr, Jimenez-Velazquez IZ, Jucker M, Klein G, Levin J, Mancini M, Masellis M, McKay NS, Mummery CJ, Ringman JM, Shimada H, Snider BJ, Suzuki K, Wallon D, Xiong C, Yaari R, McDade E, Perrin RJ, Bateman RJ, Salloway SP, Benzinger TLS, Clifford DB; Dominantly Inherited Alzheimer Network Trials Unit. Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease. Ann Neurol. 2022 Nov;92(5):729-744. doi: 10.1002/ana.26511. Epub 2022 Oct 13. PMID: 36151869.
Name: Peter Millar
Year: 2022
Reference:
Millar, PR, Luckett, PH, Gordon, BA, Benzinger, TLS, Schindler, SE, Fagan, AM, Cruchaga, C, Bateman, RJ, …, the Dominantly Inherited Alzheimer Network, Morris, JC, & Ances, BM (2022). Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease. NeuroImage, 256, 119228. DOI: 10.1016/j.neuroimage.2022.119228 PMID: 35452806.
Millar, PR, Gordon, BA, Luckett, PH, Benzinger, TLS, Cruchaga, C, Fagan, AM, Hassenstab, JJ, Perrin, RJ, Schindler, SE, …, the Dominantly Inherited Alzheimer Network, Bateman, RJ, Morris, JC, & Ances, BM (submitted). Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages.
Name: Anne Fagan
Year: 2022
Reference:
O’Connor A, Rice H, Barnes J, Ryan NS, Liu KY, Allegri RF, Berman S, Ringman JM, Cruchaga C, Farlow MR, Hassenstab J, Lee JH, Perrin RJ, Xiong C, Gordon B, Levey AI, Goate A, Graff-Radford N, Levin J, Jucker M, Benzinger T, McDade E, Mori H, Noble JM, Schofield PR, Martins RN, Salloway S, Chhatwal J, Morris JC, Bateman R, Howard R, Reeves S, Fox NC; Dominantly Inherited Alzheimer Network. First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease: the Dominantly Inherited Alzheimer’s Network Study. J Neurol Neurosurg Psychiatry. 2022 Dec 15:jnnp-2022-329843. doi: 10.1136/jnnp-2022-329843. Epub ahead of print. PMID: 36522155.
Name: Suzanne Schindler
Year: 2022
Reference:
Rosen AC, Arias JJ, Ashford JW, Blacker D, Chhatwal JP, Chin NA, Clark L, Denny SS, Goldman JS, Gleason CE, Grill JD, Heidebrink JL, Henderson VW, Lavacot JA, Lingler JH, Menon M, Nosheny RL, Oliveira FF, Parker MW, Rahman-Filipiak A, Revoori A, Rumbaugh MC, Sanchez DL, Schindler SE, Schwarz CG, Toy L, Tyrone J, Walter S, Wang LS, Wijsman EM, Zallen DT, Aggarwal NT. The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All. J Alzheimers Dis. 2022 Jul 31. PMID: 35938255.
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE, Karikari TK, Ashton NJ, Henson RL, Yarasheski KE, West T, Meyer MR, Kirmess KM, Li Y, Saef B, Moulder KL, Bradford D, Fagan AM, Gordon BA, Benzinger TLS, Balls-Berry J, Bateman RJ, Xiong C, Zetterberg H, Blennow K, Morris JC. Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light. Neurology. 2022 Apr 21. PMID: 35450967.
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE, Karikari TK. Comorbidities confound Alzheimer’s blood tests. Nature Med. 2022 Jul 4. PMID: 35788176.
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE, Karikari TK. “Comorbidities confound Alzheimer’s blood tests.” Nature Med. (2022). Schindler, S.E., Karikari, T.K. Comorbidities confound Alzheimer’s blood tests. Nature Med (2022). https://doi.org/10.1038/s41591-022-01875-3.
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE, Li Y, Li M, Despotis A, Park E, Vittert L, Hamilton BH, Womack KB, Saef B, Holtzman DM, Morris JC, Bateman RJ, Gupta MR. Using Alzheimer’s disease blood tests to accelerate clinical trial enrollment. Alzheimers Dement. 2022 Aug 7. PMID: 35934777